+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market: Size, Trends and Forecasts (2019-2023)

  • ID: 4860951
  • Report
  • November 2019
  • Region: Global
  • 113 Pages
  • Daedal Research
1 of 6

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux
  • Roche
  • Siemens Healthineers
  • MORE

Scope of the Report
The report titled “Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market: Size, Trends and Forecasts (2019-2023)”, provides an in-depth analysis of the global infectious disease in vitro diagnostic (IVD) market by value, by type, by region, etc., and the global infectious disease molecular test market by value, by infection, by end-use, by region, etc. The report provides a regional analysis of the infectious disease IVD and molecular test market, including the following regions: The US, Western Europe, Australia, and ROW. The report also provides a detailed analysis of the US, Western Europe and Australia infectious disease molecular test market by infection.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global infectious disease in vitro diagnostic (IVD) and molecular test market has also been forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global infectious disease in vitro diagnostic (IVD) and molecular test market is highly fragmented with many infectious disease IVD and molecular test market players operating worldwide. Some infectious disease IVD and molecular test market players operating on a local level while other players operating on a regional and global level. Further, key players of the market are Roche, Abbott Laboratories, BioMérieux, Siemens Healthineers are also profiled with their financial information and respective business strategies.

Country Coverage

  • The US
  • Western Europe
  • Australia
  • ROW

Company Coverage

  • Roche
  • Abbott Laboratories
  • BioMérieux
  • Siemens Healthineers
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux
  • Roche
  • Siemens Healthineers
  • MORE

1. Executive Summary

2. Introduction
2.1 Infectious Diseases: An Overview
2.1.1 General Signs and Symptoms of Infectious Diseases
2.1.2 Few Simple Precautions to Prevent Infectious Diseases
2.2 In Vitro Diagnostic (IVD): An Overview
2.2.1 In Vitro Diagnostic (IVD) Applications
2.2.2 Types of IVD Tests for Infectious Diseases
2.3 Molecular Test: An Overview
2.3.1 Molecular Test for Infectious Diseases
2.4 Molecular Test Segmentation: An Overview
2.4.1 Molecular Test for Infectious Diseases Segmentation by Infection
2.4.2 Molecular Test for Infectious Diseases Segmentation by End-use

3. Global Market Analysis
3.1 Global Infectious Disease In Vitro Diagnostic (IVD) Market: An Analysis
3.1.1 Global Infectious Disease In Vitro Diagnostic (IVD) Market by Value
3.1.2 Global Infectious Disease In Vitro Diagnostic (IVD) Market by Type (Immunoassays, Molecular Test, and Traditional Microbiology)
3.1.3 Global Infectious Disease In Vitro Diagnostic (IVD) Market by Region (The US, Western Europe, Australia, and ROW)
3.2 Global Infectious Disease In Vitro Diagnostic (IVD) Market: Type Analysis
3.2.1 Global Infectious Disease Immunoassays Market by Value
3.2.2 Global Infectious Disease Molecular Test Market by Value
3.2.3 Global Infectious Disease Molecular Test Market by Infection (Sexually Transmitted Infections (STIs), ESBL & CPO, Enteric, Respiratory (Influenza & RSV), and Other Infections)
3.2.4 Global Infectious Disease Molecular Test Market by End-use (Laboratories and Point-of-Care)
3.2.5 Global Infectious Disease Molecular Test Market by Region (The US, Western Europe, Australia, and ROW)
3.2.6 Global Infectious Disease Traditional Microbiology Market by Value
3.3 Global Infectious Disease Molecular Test Market: Infection Analysis
3.3.1 Global Enteric Molecular Test Market by Value
3.3.2 Global Influenza Molecular Test Market by Value
3.3.3 Global Respiratory Syncytial Virus (RSV) Molecular Test Market by Value
3.3.4 Global ESBL & CPO Molecular Test Market by Value
3.3.5 Global Sexually Transmitted Infections (STIs) Molecular Test Market by Value
3.3.6 Global Other Infections Molecular Test Market by Value
3.4 Global Infectious Disease Molecular Test Market: End-use Analysis
3.4.1 Global Laboratories Infectious Disease Molecular Test Market by Value
3.4.2 Global Point-of-Care (POC) Infectious Disease Molecular Test Market by Value

4. Regional Market Analysis
4.1 The US Infectious Disease In Vitro Diagnostic (IVD) Market: An Analysis
4.1.1 The US Infectious Disease In Vitro Diagnostic (IVD) Market by Value
4.1.2 The US Infectious Disease In Vitro Diagnostic (IVD) Market by Type (Molecular Test and Other Types)
4.1.3 The US Infectious Disease Molecular Test Market by Value
4.1.4 The US Infectious Disease Molecular Test Market by Infection (Sexually Transmitted Infections (STIs), Respiratory (Influenza & RSV), Enteric, Flavivirus/Alphavirus, ESBL & CPO, and Other Infections)
4.1.5 The US Enteric Molecular Test Market by Value
4.1.6 The US Respiratory (Influenza+RSV) Molecular Test Market by Value
4.1.7 The US ESBL & CPO Molecular Test Market by Value
4.1.8 The US Sexually Transmitted Infections (STIs) Molecular Test Market by Value
4.1.9 The US Flavivirus/Alphavirus Molecular Test Market by Value
4.1.10 The US Other Infections Molecular Test Market by Value
4.2 Western Europe Infectious Disease In Vitro Diagnostic (IVD) Market: An Analysis
4.2.1 Western Europe Infectious Disease In Vitro Diagnostic (IVD) Market by Value
4.2.2 Western Europe Infectious Disease In Vitro Diagnostic (IVD) Market by Type (Molecular Test and Others)
4.2.3 Western Europe Infectious Disease Molecular Test Market by Value
4.2.4 Western Europe Infectious Disease Molecular Test Market by Infection (Sexually Transmitted Infections (STIs), Respiratory (Influenza & RSV), Enteric, Flavivirus/Alphavirus, ESBL & CPO, and Other Infections)
4.2.5 Western Europe Enteric Molecular Test Market by Value
4.2.6 Western Europe Respiratory (Influenza+RSV) Molecular Test Market by Value
4.2.7 Western Europe ESBL & CPO Molecular Test Market by Value
4.2.8 Western Europe Sexually Transmitted Infections (STIs) Molecular Test Market by Value
4.2.9 Western Europe Flavivirus/Alphavirus Molecular Test Market by Value
4.2.10 Western Europe Other Infections Molecular Test Market by Value
4.3 Australia Infectious Disease In Vitro Diagnostic (IVD) Market: An Analysis
4.3.1 Australia Infectious Disease In Vitro Diagnostic (IVD) Market by Value
4.3.2 Australia Infectious Disease In Vitro Diagnostic (IVD) Market by Type (Molecular Test and Others)
4.3.3 Australia Infectious Disease Molecular Test Market by Value
4.3.4 Australia Infectious Disease Molecular Test Market by Infection Sexually Transmitted Infections (STIs), Respiratory (Influenza & RSV), Enteric, Flavivirus/Alphavirus, ESBL & CPO, and Other Infections)
4.3.5 Australia Enteric Molecular Test Market by Value
4.3.6 Australia Respiratory (Influenza+RSV) Molecular Test Market by Value
4.3.7 Australia ESBL & CPO Molecular Test Market by Value
4.3.8 Australia Sexually Transmitted Infections (STIs) Molecular Test Market by Value
4.3.9 Australia Flavivirus/Alphavirus Molecular Test Market by Value
4.3.10 Australia Other Infections Molecular Test Market by Value
4.4 ROW Infectious Disease In Vitro Diagnostic (IVD) Market: An Analysis
4.4.1 ROW Infectious Disease In Vitro Diagnostic (IVD) Market by Value
4.4.2 ROW Infectious Disease In Vitro Diagnostic (IVD) Market by Type (Molecular Test and Others)
4.4.3 ROW Infectious Disease Molecular Test Market by Value

5. Market Dynamics
5.1 Growth Driver
5.1.1 Growing Geriatric Population
5.1.2 Rising Affordability
5.1.3 Increasing Prevalence of Infectious Diseases
5.1.4 Escalating Healthcare Spending
5.1.5 Rapid Urbanization
5.1.6 Growing Preference of Point-of-Care (POC) Diagnostics/Testing
5.2 Challenges
5.2.1 High Cost Involved
5.2.2 Stringent Government Regulations
5.3 Market Trends
5.3.1 Integration of Internet of Things (IoT) Features into IVD
5.3.2 Growing Acceptance for Personalized Medicine
5.3.3 Increasing Demand for Lab Automation

6. Competitive Landscape
6.1 Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Players: A Financial Comparison
6.2 Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Players by Research & Development Expenses

7. Company Profiles
7.1 Roche
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Abbott Laboratories
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 BioMérieux
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Siemens Healthineers
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy

List of Figures
Figure 1: General Signs and Symptoms of Infectious Diseases
Figure 2: Few Simple Precautions to Prevent Infectious Diseases
Figure 3: In Vitro Diagnostic (IVD) Applications
Figure 4: Types of IVD Tests for Infectious Diseases
Figure 5: Molecular Test for Infectious Diseases Segmentation by Infection
Figure 6: Molecular Test for Infectious Diseases Segmentation by End-use
Figure 7: Global Infectious Disease IVD Market by Value; 2017-2018 (US$ Billion)
Figure 8: Global Infectious Disease IVD Market by Value; 2019-2023 (US$ Billion)
Figure 9: Global Infectious Disease IVD Market by Type; 2018 (Percentage, %)
Figure 10: Global Infectious Disease IVD Market by Region; 2018 (Percentage, %)
Figure 11: Global Infectious Disease Immunoassays Market by Value; 2018-2023 (US$ Billion)
Figure 12: Global Infectious Disease Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 13: Global Infectious Disease Molecular Test Market by Infection; 2018 (Percentage, %)
Figure 14: Global Infectious Disease Molecular Test Market by End-use; 2018 (Percentage, %)
Figure 15: Global Infectious Disease Molecular Test Market by Region; 2018 (Percentage, %)
Figure 16: Global Infectious Disease Traditional Microbiology Market by Value; 2018-2023 (US$ Billion)
Figure 17: Global Enteric Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 18: Global Influenza Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 19: Global RSV Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 20: Global ESBL & CPO Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 21: Global STIs Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 22: Global Other Infections Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 23: Global Laboratories Infectious Disease Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 24: Global Point-of-Care (POC) Infectious Disease Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 25: The US Infectious Disease IVD Market by Value; 2018-2023 (US$ Billion)
Figure 26: The US Infectious Disease IVD Market by Type; 2018 (Percentage, %)
Figure 27: The US Infectious Disease Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 28: The US Infectious Disease Molecular Test Market by Infection; 2018 (Percentage, %)
Figure 29: The US Enteric Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 30: The US Respiratory (Influenza+RSV) Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 31: The US ESBL & CPO Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 32: The US STIs Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 33: The US Flavivirus/Alphavirus Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 34: The US Other Infections Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 35: Western Europe Infectious Disease IVD Market by Value; 2018-2023 (US$ Billion)
Figure 36: Western Europe Infectious Disease IVD Market by Type; 2018 (Percentage, %)
Figure 37: Western Europe Infectious Disease Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 38: Western Europe Infectious Disease Molecular Test Market by Infection; 2018 (Percentage, %)
Figure 39: Western Europe Enteric Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 40: Western Europe Respiratory (Influenza+RSV) Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 41: Western Europe ESBL & CPO Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 42: Western Europe STIs Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 43: Western Europe Flavivirus/Alphavirus Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 44: Western Europe Other Infections Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 45: Australia Infectious Disease IVD Market by Value; 2018-2023 (US$ Million)
Figure 46: Australia Infectious Disease IVD Market by Type; 2018 (Percentage, %)
Figure 47: Australia Infectious Disease Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 48: Australia Infectious Disease Molecular Test Market by Infection; 2018 (Percentage, %)
Figure 49: Australia Enteric Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 50: Australia Respiratory (Influenza+RSV) Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 51: Australia ESBL & CPO Molecular Test Market by Value; 2018-2023 (US$ Thousand)
Figure 52: Australia STIs Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 53: Australia Flavivirus/Alphavirus Molecular Test Market by Value; 2018-2023 (US$ Thousand)
Figure 54: Australia Other Infections Molecular Test Market by Value; 2018-2023 (US$ Million)
Figure 55: ROW Infectious Disease IVD Market by Value; 2018-2023 (US$ Billion)
Figure 56: ROW Infectious Disease IVD Market by Type; 2018 (Percentage, %)
Figure 57: ROW Infectious Disease Molecular Test Market by Value; 2018-2023 (US$ Billion)
Figure 58: Global Aging Population by Region; 2010-2040 (Percentage, %)
Figure 59: Global GDP in PPP Terms; 2000-2020 (US$ Trillion)
Figure 60: The US Estimated Influenza Disease Burden by Season; 2011-2018 (Million)
Figure 61: Global Healthcare Spending by Region; 2017-2022 (US$ Billion)
Figure 62: Global Urbanization Rates by Region; 2010-2040 (Percentage, %)
Figure 63: Global Point-of-Care (POC) Diagnostics/Testing Market; 2018-2024 (US$ Billion)
Figure 64: Global IoT Healthcare Market; 2017-2022 (US$ Billion)
Figure 65: Global Infectious Disease IVD and Molecular Test Market Players by Research & Development (R&D) Expenses; 2017-2018 (US$ Million)
Figure 66: Roche Sales; 2014-2018 (US$ Billion)
Figure 67: Roche Sales by Segments; 2018 (Percentage, %)
Figure 68: Roche Sales by Region; 2018 (Percentage, %)
Figure 69: Abbott Laboratories Net Sales; 2014-2018 (US$ Billion)
Figure 70: Abbott Laboratories Net Sales by Segments; 2018 (Percentage, %)
Figure 71: Abbott Laboratories Net Sales by Region; 2018 (Percentage, %)
Figure 72: BioMérieux Sales; 2014-2018 (US$ Billion)
Figure 73: BioMérieux Sales by Application; 2018 (Percentage, %)
Figure 74: BioMérieux Sales by Region; 2018 (Percentage, %)
Figure 75: Siemens Healthineers Revenue; 2015-2018 (US$ Billion)
Figure 76: Siemens Healthineers Revenue by Segments; 2018 (Percentage, %)
Figure 77: Siemens Healthineers Revenue by Region; 2018 (Percentage, %)

List of Tables
Table 1: Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Players: A Financial Comparison; 2018

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • BioMérieux
  • Roche
  • Siemens Healthineers
  • MORE

Infectious diseases are illnesses caused by microorganisms, such as bacteria, viruses, fungi or parasites. The infectious diseases can be spread either through direct contact or through indirect contact. Some infectious diseases are transmitted by insects or animals bite, and by the contaminated food, water, soil, or plants.

In Vitro Diagnostic (IVD) test are performed on human samples such as blood, urine, tissue and other body fluids. These tests are used to detect and diagnose diseases. In the case of infectious diseases, IVD tests are used to detect and identify the responsible infectious agent, and to allow healthcare professionals to find out the appropriate treatment for the patient. There are three types of IVD tests for infectious diseases: Traditional microbiology, Immunoassays, and Molecular Tests.

Molecular IVD tests are used to detect active and latent patient infections by targeting genetic sequences (DNA or RNA) specific to bacteria, viruses, fungi or parasites. Molecular test possess advantages such as high sensitivity, high specificity, and rapid results. The infectious disease molecular test market can be segmented on the basis of infection (Enteric, Influenza, Respiratory Syncytial Virus (RSV), ESBL & CPO, Sexually Transmitted Infections (STIs), Flavivirus/Alphavirus, and Other Infections); and End-use (Laboratories and Point-of-care).

The global infectious disease In Vitro Diagnostic (IVD) and Molecular Test market has increased significantly during the years 2017-2018 and projections are made that the market would rise in the next four years i.e. 2019-2023 tremendously. The infectious disease In Vitro Diagnostic (IVD) and Molecular Test market is expected to increase due to growing geriatric population, rising affordability, increasing the prevalence of infectious diseases, escalating healthcare spending, growing preference of point-of-care diagnostics/testing, etc. Yet the market faces some challenges such as the high cost involved, stringent government regulations, etc.

Note: Product cover images may vary from those shown
5 of 6
  • Abbott Laboratories
  • BioMérieux
  • Roche
  • Siemens Healthineers
Note: Product cover images may vary from those shown
6 of 6

The author's core strengths include a seasoned management team, a highly demonstrable track record of seamless process integration and consistent delivery position. The research team uses its extensive knowledge of the various industries to analyze the market trends from both a vendor and an end-user perspective.

The research strategy is focused on high-quality secondary data combined with elaborate use of primary data. The team of research analysts provides a 360-degree overview of available data.

The analysts begin by searching industry reports, surveys, trade publications, company reports and press releases. They also include information gained by extensive interviews with major players and industry participants.

The background information, related to industry statistics, is provided by the author's proprietary databases.

The information is then analyzed and synthesized into a report - with market forecast, industry trends, and competitive strategies. The team of research analysts use both qualitative tools and quantitative techniques to get an insight into the industry.

The author's core expertise lies in researching, compiling and analyzing vast amounts of publicly available information and premier databases, into widely read reports.

 

Loading
LOADING...

Adroll
adroll